Sexual HealthLimited Research⚠️ Not Approved — CautionC

Melanotan II

MT-II · Non-selective melanocortin receptor agonism (MC1R, MC3R, MC4R, MC5R); MC1R activation produces melanin for tanning; MC4R activation causes penile erection and appetite suppression; lacks MC2R selectivity causing adrenal side effects

Last reviewed . First published . By the PeptIQ team.

Educational and observational reference only. Not medical advice. Community charts use live PeptIQ self-reports.

Studies cited
5
Research grade
C
Experience
99

Overall check-ins

Activity
85

Trackers & reports

Typical Dose

Research: 0.5–1 mg (extreme caution; not recommended)

Route

Injectable

Cycle

Not recommended for ongoing use

Storage

2–8°C Refrigerated

What is Melanotan II?

Melanotan II (MT-II) is a synthetic analog of α-melanocyte-stimulating hormone (α-MSH) studied for skin tanning, erectile function, and appetite suppression. Not FDA-approved and associated with significant safety concerns including dangerous nausea, uncontrolled melanocytic changes (nevi/moles), hypertension, and priapism. The FDA has issued multiple warnings. Banned from 503A compounding. Use with extreme caution.

Mechanism of Action

Non-selective melanocortin receptor agonism (MC1R, MC3R, MC4R, MC5R); MC1R activation produces melanin for tanning; MC4R activation causes penile erection and appetite suppression; lacks MC2R selectivity causing adrenal side effects

Target: MC1R, MC3R, MC4R, MC5R (non-selective)

Research Indications

Sexual FunctionEffective

Research and clinical data supporting effects on sexual response

Libido SupportEffective

Clinical data shows improvements in desire and arousal metrics

Melanocortin ActivityModerate

Acts via central nervous system melanocortin receptor pathways

Research Protocols

These are commonly discussed research protocols — not medical advice. Consult a healthcare provider before use.

GoalDoseFrequencyRoute
Starting DoseLow dosePer protocolVaries
Standard DoseTitratedPer protocolVaries

Peptide & Drug Interactions

Always consult your healthcare provider before combining with other compounds. Use our Interaction Checker for reference.

PDE5 Inhibitors (Sildenafil, Tadalafil)Monitor
Blood Pressure MedicationsCaution
Other Melanocortin AgonistsAvoid
NaltrexoneMonitor

How to Reconstitute & Inject

Use bacteriostatic (BAC) water only. Avoid saline — may cause precipitation. Refrigerate and use within 28 days.

  1. 1

    Remove Melanotan II vial from refrigeration and allow to reach room temperature (15–20 minutes)

  2. 2

    Clean vial top with alcohol swab and allow to air dry completely

  3. 3

    Using a sterile syringe, draw the calculated volume of bacteriostatic water (BAC water)

  4. 4

    Inject BAC water slowly down the side of the vial — do not aim directly at the powder

  5. 5

    Gently swirl in circular motions — DO NOT shake vigorously as this degrades the peptide

  6. 6

    Allow 2–3 minutes for full dissolution — solution should be clear and colorless

  7. 7

    Draw calculated dose into an insulin syringe for subcutaneous injection

  8. 8

    Inject into abdomen, thigh, or upper arm. Rotate injection sites to prevent lipodystrophy

  9. 9

    Store reconstituted solution refrigerated (2–8°C) and use within 28 days

What to Expect

Week 1–2

Initial effects and adaptation period. Monitor for any adverse reactions.

Week 2–4

Primary effects begin to manifest. Adjust dosing as recommended by your provider.

Week 4–8

Main therapeutic effects should be established. Assess progress with your provider.

Week 8+

Evaluate results and determine continuation, cycling, or dose adjustments.

Side Effects & Safety

  • Injection site reactions (redness, bruising, mild pain)
  • Potential for allergic reaction — discontinue if rash or hives occur
  • Individual reactions vary — start at the lowest dose and monitor carefully
  • Consult your healthcare provider before use and report any unusual symptoms

Melanotan II is not FDA-approved and cannot be prepared by 503A compounding pharmacies. PeptIQ does not sell peptides or list vendors. Talk with a licensed clinician.

FDA Status & Regulatory Info

⚠️ Not Approved — Caution

Melanotan II (MT-II) is a synthetic analog of α-melanocyte-stimulating hormone (α-MSH) studied for skin tanning, erectile function, and appetite suppression. Not FDA-approved and associated with significant safety concerns including dangerous nausea, uncontrolled melanocytic changes (nevi/moles), hypertension, and priapism. The FDA has issued multiple warnings. Banned from 503A compounding. Use with extreme caution.

Rx Required: No
503A Ban: Yes
Telehealth: N/A
Full FDA Status Tracker

Frequently Asked Questions

Community-reported data

The information below reflects self-reported experiences from PeptIQ app users. It is not clinical evidence and should not replace professional medical advice.

What 46 users report

Observational self-reports from live PeptIQ aggregates. Not clinical outcomes.

46 community reports

Overall experience

From check-in ratings — separate from side effects logged below. Side effects are logged separately from overall experience. A favorable check-in can still include nausea, fatigue, or injection-site reactions.

Favorable 97% · Mixed 3% · Unfavorable overall 0%

Most reported benefits

Benefits users selected when logging a favorable or mixed check-in.

Libido
142
Mood
141
Appetite
73

Most logged side effects

Side effects are logged separately from overall experience. A favorable check-in can still include nausea, fatigue, or injection-site reactions.

Fatigue
2
Nausea
2

Self-reported dose per injection

Median bucket: 0.4–0.6 mg · Most common: 0.2–0.4 mg

Reports span 0.01–2 mg

0.01–0.025 mg
1
0.05–0.1 mg
1
0.1–0.2 mg
7
0.2–0.4 mg
49
0.4–0.6 mg
23
0.6–1 mg
33
1–2 mg
28

Anonymized self-reports from PeptIQ users — not prescribing guidance. Buckets group similar logged amounts; open-ended top buckets mean “at least” that dose.

How repeat users are trending

Among repeat reporters, 94% said they felt similar to their last entry, 6% more positive, and 0% more negative.

Overall, repeat reporters leaned more positive than their previous entry.

Median gap between entries: 50 days · Based on 32 repeat reporters

Share Your Experience

Rate Melanotan II in the PeptIQ app and help the community make informed decisions.

Research References (3)

Cited PubMed, trial registry, and label sources for education only. We do not control third-party content.

  1. PubMed

    LC-HRMS characterization of the skin pigmentation and sexual enhancers melanotan II and bremelanotide sold on the black market of performance and image enhancing drugs

    Mestria S, Odoardi S, Frison G, et al. Drug testing and analysis. 2021

    Source
    Wiki study page →
  2. PubMed

    Melanotan II injection resulting in systemic toxicity and rhabdomyolysis

    Nelson ME, Bryant SM, Aks SE. Clinical toxicology (Philadelphia, Pa.). 2012

    Source
    Wiki study page →

Wiki tools

Observational indexes and compare views for Melanotan II.

Educational information only

This page is for educational reference. It is not medical or legal advice. PeptIQ does not sell peptides or list vendors. Consult the FDA and a licensed healthcare professional for current regulations and individualized guidance.

PeptIQ app

Log your Melanotan II protocol in PeptIQ

Turn this Melanotan II guide into a living protocol — doses, vials, and history in one place.

Track Melanotan IIOpen web app

iOS, Android, and web

Ask PeptIQ

Two taps on our guided quiz, then keep going in iMessage with sources — not Instagram screenshots.

Start the quizOr try Peptide X Quiz →

Quick Facts

Half-Life
~33 minutes
Target
MC1R, MC3R, MC4R, MC5R (non-selective)
Route
Injectable
Availability
Varies
Rx Required
No
503A Ban
Yes
Browse peptide education

Talk with a clinician

PeptIQ is education only. We do not sell peptides or list vendors. Discuss Melanotan II with a licensed healthcare provider — not medical advice, not a prescription.

Download PeptIQ

Wiki tools

Observational indexes and compare views for Melanotan II.